Literature DB >> 19137480

Retention in treatment--indicator or illusion: an essay.

Robert Walker1.   

Abstract

This article poses questions about the meaning of retention in substance user treatment. Retention has become a "gold standard" for substance user-treatment programs, suggesting it has become more than an indicator of positive outcomes, but a positive treatment outcome in its own right. Retention has been studied in numerous ways and has been associated with positive treatment outcomes, but questions remain about whether it has assumed greater importance than it merits. For example, it may be an artifact of other client personality characteristics that are also associated with more positive outcomes. Conversely, it may be a function of the interaction of treatment environment and client. This article suggests a need to broaden the scope of treatment-retention studies and to compare retention rates across other medical treatment environments to see if failure to complete treatment is a function of substance user treatment or of all treatment processes as well as other types of planned change processes.

Mesh:

Year:  2009        PMID: 19137480     DOI: 10.1080/10826080802525967

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  7 in total

1.  High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Authors:  Maria Eugenia Socías; Evan Wood; Stephanie Lake; Seonaid Nolan; Nadia Fairbairn; Kanna Hayashi; Hennady P Shulha; Seagle Liu; Thomas Kerr; M-J Milloy
Journal:  Addiction       Date:  2018-09-20       Impact factor: 6.526

2.  Stress, craving and mood as predictors of early dropout from opioid agonist therapy.

Authors:  Leigh V Panlilio; Samuel W Stull; William J Kowalczyk; Karran A Phillips; Jennifer R Schroeder; Jeremiah W Bertz; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; Edward V Nunes; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2019-07-16       Impact factor: 4.492

3.  Study results from the Clinical Trials Network's first 10 years: where do they lead?

Authors:  Elizabeth A Wells; Andrew J Saxon; Donald A Calsyn; Thomas R Jackson; Dennis M Donovan
Journal:  J Subst Abuse Treat       Date:  2010-06

Review 4.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

5.  Coerced addiction treatment: Client perspectives and the implications of their neglect.

Authors:  Karen A Urbanoski
Journal:  Harm Reduct J       Date:  2010-06-20

Review 6.  An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers.

Authors:  Sarah H Heil; Teresa Linares Scott; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2009-06-21       Impact factor: 4.492

7.  Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials.

Authors:  Leigh V Panlilio; Samuel W Stull; Jeremiah W Bertz; Albert J Burgess-Hull; William J Kowalczyk; Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2020-09-29       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.